107 related articles for article (PubMed ID: 16801977)
1. The procholinergic effects of the atypical antipsychotic olanzapine are independent of muscarinic autoreceptor inhibition.
Tzavara ET; Bymaster FP; Nomikos GG
Mol Psychiatry; 2006 Jul; 11(7):619-21. PubMed ID: 16801977
[No Abstract] [Full Text] [Related]
2. Dysregulated hippocampal acetylcholine neurotransmission and impaired cognition in M2, M4 and M2/M4 muscarinic receptor knockout mice.
Tzavara ET; Bymaster FP; Felder CC; Wade M; Gomeza J; Wess J; McKinzie DL; Nomikos GG
Mol Psychiatry; 2003 Jul; 8(7):673-9. PubMed ID: 12874603
[TBL] [Abstract][Full Text] [Related]
3. Influence of chronic treatment with olanzapine, clozapine and scopolamine on performance of a learned 8-arm radial maze task in rats.
Ortega-Alvaro A; Gibert-Rahola J; Micó JA
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan; 30(1):104-11. PubMed ID: 16226364
[TBL] [Abstract][Full Text] [Related]
4. Effects of anticholinergic drugs selective for muscarinic receptor subtypes on prepulse inhibition in mice.
Ukai M; Okuda A; Mamiya T
Eur J Pharmacol; 2004 May; 492(2-3):183-7. PubMed ID: 15178363
[TBL] [Abstract][Full Text] [Related]
5. Muscarinic (M) receptors in coronary circulation: gene-targeted mice define the role of M2 and M3 receptors in response to acetylcholine.
Lamping KG; Wess J; Cui Y; Nuno DW; Faraci FM
Arterioscler Thromb Vasc Biol; 2004 Jul; 24(7):1253-8. PubMed ID: 15130910
[TBL] [Abstract][Full Text] [Related]
6. The role of muscarinic receptor antagonism in antipsychotic-induced hippocampal acetylcholine release.
Johnson DE; Nedza FM; Spracklin DK; Ward KM; Schmidt AW; Iredale PA; Godek DM; Rollema H
Eur J Pharmacol; 2005 Jan; 506(3):209-19. PubMed ID: 15627430
[TBL] [Abstract][Full Text] [Related]
7. In Silico Analysis of Binding Interaction of Mamba Toxins with M4 and M2 Muscarinic Acetylcholine Receptors for Therapeutic Use in Alzheimer's Disease.
Waqar M; Kamal MA; Batool S
CNS Neurol Disord Drug Targets; 2015; 14(8):1031-40. PubMed ID: 26295818
[TBL] [Abstract][Full Text] [Related]
8. Loss of muscarinic autoreceptor function impairs long-term depression but not long-term potentiation in the striatum.
Bonsi P; Martella G; Cuomo D; Platania P; Sciamanna G; Bernardi G; Wess J; Pisani A
J Neurosci; 2008 Jun; 28(24):6258-63. PubMed ID: 18550768
[TBL] [Abstract][Full Text] [Related]
9. Opposing functions of spinal M2, M3, and M4 receptor subtypes in regulation of GABAergic inputs to dorsal horn neurons revealed by muscarinic receptor knockout mice.
Zhang HM; Chen SR; Matsui M; Gautam D; Wess J; Pan HL
Mol Pharmacol; 2006 Mar; 69(3):1048-55. PubMed ID: 16365281
[TBL] [Abstract][Full Text] [Related]
10. A novel muscarinic M(4) receptor antagonist provides further evidence of an autoreceptor role for the muscarinic M(2) receptor sub-type.
Kitaichi K; Day JC; Quirion R
Eur J Pharmacol; 1999 Oct; 383(1):53-6. PubMed ID: 10556681
[TBL] [Abstract][Full Text] [Related]
11. Muscarinic mechanisms of antipsychotic atypicality.
Bymaster FP; Felder CC; Tzavara E; Nomikos GG; Calligaro DO; Mckinzie DL
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Oct; 27(7):1125-43. PubMed ID: 14642972
[TBL] [Abstract][Full Text] [Related]
12. M2 muscarinic autoreceptors modulate acetylcholine release in prefrontal cortex of C57BL/6J mouse.
Douglas CL; Baghdoyan HA; Lydic R
J Pharmacol Exp Ther; 2001 Dec; 299(3):960-6. PubMed ID: 11714883
[TBL] [Abstract][Full Text] [Related]
13. The muscarinic acetylcholine receptor agonist BuTAC mediates antipsychotic-like effects via the M4 subtype.
Watt ML; Rorick-Kehn L; Shaw DB; Knitowski KM; Quets AT; Chesterfield AK; McKinzie DL; Felder CC
Neuropsychopharmacology; 2013 Dec; 38(13):2717-26. PubMed ID: 23907402
[TBL] [Abstract][Full Text] [Related]
14. GRK5 deficiency leads to reduced hippocampal acetylcholine level via impaired presynaptic M2/M4 autoreceptor desensitization.
Liu J; Rasul I; Sun Y; Wu G; Li L; Premont RT; Suo WZ
J Biol Chem; 2009 Jul; 284(29):19564-71. PubMed ID: 19478075
[TBL] [Abstract][Full Text] [Related]
15. M4 muscarinic receptors regulate the dynamics of cholinergic and dopaminergic neurotransmission: relevance to the pathophysiology and treatment of related CNS pathologies.
Tzavara ET; Bymaster FP; Davis RJ; Wade MR; Perry KW; Wess J; McKinzie DL; Felder C; Nomikos GG
FASEB J; 2004 Sep; 18(12):1410-2. PubMed ID: 15231726
[TBL] [Abstract][Full Text] [Related]
16. Olanzapine: preclinical pharmacology and recent findings.
Moore NA
Br J Psychiatry Suppl; 1999; (37):41-4. PubMed ID: 10211141
[TBL] [Abstract][Full Text] [Related]
17. M2 and M3 muscarinic receptors are involved in enteric nerve-mediated contraction of the mouse ileum: Findings obtained with muscarinic-receptor knockout mouse.
Takeuchi T; Tanaka K; Nakajima H; Matsui M; Azuma YT
Am J Physiol Gastrointest Liver Physiol; 2007 Jan; 292(1):G154-64. PubMed ID: 17008557
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antagonistic activity at muscarinic receptor subtypes of some derivatives of diphenidol.
Varoli L; Angeli P; Buccioni M; Burnelli S; Cavalli A; Marucci G; Recanatini M
Farmaco; 2003 Sep; 58(9):651-7. PubMed ID: 13679157
[TBL] [Abstract][Full Text] [Related]
19. Rewarding effects of M4 but not M3 muscarinic cholinergic receptor antagonism in the rostromedial tegmental nucleus.
Buie N; Sodha D; Scheinman SB; Steidl S
Behav Brain Res; 2020 Feb; 379():112340. PubMed ID: 31697984
[TBL] [Abstract][Full Text] [Related]
20. Scopolamine induces disruption of latent inhibition which is prevented by antipsychotic drugs and an acetylcholinesterase inhibitor.
Barak S; Weiner I
Neuropsychopharmacology; 2007 May; 32(5):989-99. PubMed ID: 16971898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
